{
  "title": "Special Episode: The Winding Road to Herd Immunity, Pt. 2",
  "description": "<p>Chief Cross-Asset Strategist Andrew Sheets and Biotech equity analyst Matthew Harrison continue their conversation, with a focus on international progress for COVID-19 vaccinations<strong>.</strong></p>",
  "itunes:title": "Special Episode: The Winding Road to Herd Immunity, Pt. 2",
  "itunes:episodeType": "full",
  "itunes:episode": 326,
  "itunes:summary": "Chief Cross-Asset Strategist Andrew Sheets and Biotech equity analyst Matthew Harrison continue their conversation, with a focus on international progress for COVID-19 vaccinations.",
  "content:encoded": "<p>Chief Cross-Asset Strategist Andrew Sheets and Biotech equity analyst Matthew Harrison continue their conversation, with a focus on international progress for COVID-19 vaccinations<strong>.</strong></p>",
  "guid": "gid://art19-episode-locator/V0/NAdILjGSKN9Gc01HcKQuclYi6kDW5fN_EO5cE57o4E8",
  "pubDate": "Fri, 19 Mar 2021 20:43:45 -0000",
  "itunes:explicit": "no",
  "itunes:image": "",
  "itunes:duration": "00:08:15",
  "enclosure": ""
}